Cognizant Technology Solutions Corp vs UnitedHealth Group Inc — how do they compare? Cognizant Technology Solutions Corp trades at $59.2 (market cap $27.03B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 12.3× Cognizant Technology Solutions Corp's market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Cognizant Technology Solutions Corp for 57 Days and UnitedHealth Group Inc for 97 Days on average.
| CTSH | UNH | |
|---|---|---|
Market Cap | $27.03B | $332.96B |
Volume | 9,883,888 | 7,273,749 |
Sector | Technology | Health |
52-Week High | $86.70 | $436.35 |
52-Week Low | $38.73 | $259.02 |
Typical Hold Time | 57 Days | 97 Days |
Enterprise Value | $28.08B | $374.82B |
Dividend Yield | 2.2% | 2.5% |
Signals from Pluang's Aura AI — not financial advice
CTSH trades at $60.01, up 5.15% with a bullish technical signal. Recent earnings beat expectations in Q4 2025 and Q1 2026, though Q2 2026 missed. The company shows solid fundamentals with a P/E of 12.88 and net income margin of 10.26%. Positive news includes AI partnerships and employer awards, supporting investor confidence.
The outlook is positive with a consensus price target of $64.25, indicating potential upside. Risks include competitive pressures in IT services and reliance on AI adoption. Strong cash flow and low debt bolster stability, but market volatility and economic headwinds remain concerns for sustained growth.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →